Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-26

Clinical Trial Update: Gadobutrol Enhanced MRA of the Renal Arteries [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating gadobutrol-enhanced magnetic resonance angiography of the renal arteries has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gadavist (gadobutrol)

Snippet

Sponsor: Bayer | Conditions: Renal Artery Obstruction | Phase 3 | Status: COMPLETED | Results posted: 2015-08-26